Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia

被引:27
|
作者
Graupner, Oliver [1 ]
Karge, Anne [1 ]
Flechsenhar, Sarah [1 ]
Seiler, Alina [1 ]
Haller, Bernhard [2 ]
Ortiz, Javier U. [1 ]
Lobmaier, Silvia M. [1 ]
Axt-Fliedner, Roland [3 ]
Enzensberger, Christian [3 ]
Abel, Kathrin [1 ]
Kuschel, Bettina [1 ]
机构
[1] Univ Hosp rechts Isar, Syst Univ Munich, Dept Obstet, Gynecology, Ismaninger Str. 22, DE-81675 Munich, Germany
[2] Univ Hosp rechts Isar, Syst Univ Munich,Inst Med Informat,Stat,Epidmiol, IMedIS, Munich, Germany
[3] Univ Hosp UKGM, Liebig Univ,Dept Obstet,Div Prenatal Med, Gynecology,Justus, Giessen, Germany
关键词
Preeclampsia; (anti-) Angiogenic factors; Placental growth factor; Soluble fms-like tyrosine kinase 1; Cerebroplacental ratio; Uterine artery Doppler; FETAL-GROWTH RESTRICTION; UTERINE ARTERY DOPPLER; CEREBROPLACENTAL RATIO; ANGIOGENIC FACTORS; PREGNANCY; WOMEN; RISK; TERM; CLASSIFICATION; DIAGNOSIS;
D O I
10.1007/s00404-019-05365-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose The sFlt-1 (soluble fms-like tyrosine kinase-1)/PlGF (placental growth factor) ratio and uterine artery Doppler have shown to be helpful in the diagnosis of pre-eclampsia (PE). The predictive value of the cerebroplacental ratio (CPR) regarding adverse perinatal outcome (APO) in low-risk pregnancies is intensively discussed. We evaluated the extent to which sFlt-1/PlGF ratio and feto-maternal Doppler may be useful in predicting APO in singleton pregnancies complicated by late-onset PE and/or HELLP syndrome. Methods This is a retrospective study from 2010 to 2018 consisting of singleton pregnancies with confirmed diagnosis of late-onset (lo >= 34 weeks) PE/HELLP syndrome in which sFlt-1/PlGF ratio and feto-maternal Doppler (mUtA-PI: mean uterine artery pulsatility index and CPR) were determined. The ability of sFlt-1/PlGF ratio, mUtA-PI, CPR and their combination to predict APO or SGA was evaluated using receiver operating characteristic (ROC) curves. Results 67 patients were included in the final analysis. Of these, sFlt-1/PlGF was > 110 (defining angiogenic lo PE) in 40.3% (27/67), mUtA-PI was above the 95th centile in 34.3% (23/67) patients and CPR was lower than the 5th centile in 10.4% (7/67). Abnormal sFlt-1/PlGF and mUtA-PI as well as CPR were associated with a lower birth weight (BW). Late-preterm birth (< 37 weeks) as well as postnatal diagnosis of small for gestational age (SGA: BW < 3rd centile) was significantly more often in angiogenic lo PE cases. Neither sFlt-1/PIGF nor CPR or mUtA-PI were APO predictors. Only for sFlt-1/PlGF, ROC analysis revealed a significant predictive value for postnatal SGA (AUC = 0.856, p = 0.001, 95% CI 0.75-0.97). There was no statistical added value of combined SGA predictors as compared to sFlt-1/PlGF alone. Conclusions In patients with lo PE, adding sFlt-1/PlGF ratio to routine antepartum fetal surveillance may be useful to identify cases of postnatal SGA. However, further prospective studies are warranted to define the role of feto-maternal Doppler and sFlt-1/PlGF ratio as outcome predictors.
引用
收藏
页码:375 / 385
页数:11
相关论文
共 50 条
  • [1] Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia
    Oliver Graupner
    Anne Karge
    Sarah Flechsenhar
    Alina Seiler
    Bernhard Haller
    Javier U. Ortiz
    Silvia M. Lobmaier
    Roland Axt-Fliedner
    Christian Enzensberger
    Kathrin Abel
    Bettina Kuschel
    Archives of Gynecology and Obstetrics, 2020, 301 : 375 - 385
  • [2] Role of sFlt-1/PlGF ratio in predicting clinical outcome in pre-eclampsia
    Chatterjee, Arpan
    Mahmood, Nargis
    Rajasri, Aylur G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 50 - 50
  • [3] Evaluation of sFlt-1/PlGF for prediction of pre-eclampsia
    Kanani, F.
    Asher, N.
    Majeed, M.
    Shuja, S.
    Ghouri, N.
    Zubairi, A.
    CLINICA CHIMICA ACTA, 2024, 558 : 58 - 58
  • [4] Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia
    Gomez-Arriaga, P. I.
    Herraiz, I.
    Lopez-Jimenez, E. A.
    Gomez-Montes, E.
    Denk, B.
    Galindo, A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (05) : 530 - 537
  • [5] Serum sFlt-1/PlGF ratio has better diagnostic ability in early- compared to late-onset pre-eclampsia
    Chuah, Theng Theng
    Tey, Wan Shi
    Ng, Mor Jack
    Tan, Edward T. H.
    Chern, Bernard
    Tan, Kok Hian
    JOURNAL OF PERINATAL MEDICINE, 2019, 47 (01) : 35 - 40
  • [6] Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia
    Gomez-Arriaga, P. I.
    Herraiz, I.
    Lopez-Jimenez, E. A.
    Escribano, D.
    Denk, B.
    Galindo, A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2014, 43 (05) : 525 - 532
  • [7] sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)
    Perales, A.
    Delgado, J. L.
    De la Calle, M.
    Garcia-Hernandez, J. A.
    Escudero, A. I.
    Campillos, J. M.
    Sarabia, M. D.
    Laiz, B.
    Duque, M.
    Navarro, M.
    Calmarza, P.
    Hund, M.
    Alvarez, F. V.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 50 (03) : 373 - 382
  • [8] sFlt-1/PlGF ratio test for pre-eclampsia: an economic assessment for the UK
    Vatish, M.
    Strunz-Mckendry, T.
    Hund, M.
    Allegranza, D.
    Wolf, C.
    Smare, C.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 48 (06) : 765 - 771
  • [9] Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF
    Tan, M. Y.
    Wright, D.
    Koutoulas, L.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 49 (02) : 201 - 208
  • [10] Midpregnancy prediction of pre-eclampsia using serum biomarkers sFlt-1 and PlGF
    Black, Carin
    Al-Amin, Ahmed
    Stolarek, Caroline
    Kane, Stefan C.
    Rolnik, Daniel Lorber
    White, Adrienne
    Costa, Fabricio da Silva
    Brennecke, Shaun
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2019, 16 : 112 - 119